Cargando…
MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
BACKGROUND: Clinically hypomyopathic dermatomyositis is a rare disease that is important to recognize, investigate and treat early as it is associated with poor prognosis. In a proportion of patients, myositis specific antibodies could be negative, but with high clinical suspicion, myositis associat...
Autores principales: | Alqatari, Safi, Riddell, Peter, Harney, Sinead, Henry, Michael, Murphy, Grainne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905122/ https://www.ncbi.nlm.nih.gov/pubmed/29665800 http://dx.doi.org/10.1186/s12890-018-0622-8 |
Ejemplares similares
-
Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
por: Selva-O’Callaghan, A., et al.
Publicado: (2021) -
Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022) -
Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022) -
2. Two cases of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease
por: Levasseur, Kirsty, et al.
Publicado: (2019) -
Congenital Lobar Overinflation Presenting with Recurrent Pneumothoraces
por: Hanžič, Nina, et al.
Publicado: (2019)